gene-silencing
-

HD Therapeutics Conference 2013 Updates: Day 2
Day 2 of our coverage of the Huntington's Disease Therapeutics Conference
-

Major Roche-Isis deal boosts Huntington's disease gene silencing
'ASO' gene silencing drugs for HD boosted by major deal between Isis Pharmaceuticals and Roche
-

Lost in translation? New insights into the making of the Huntington's disease protein
Production of normal-length & extra-long huntingtin is controlled differently. A new way to keep cells healthy in HD?
-

Giving Huntington's disease the finger? Two teams report success for zinc-finger drugs in cells and mice
Success in Huntington’s disease cells and mice for zinc finger drugs that reduce production of the harmful protein
-

Interview: Alice and Nancy Wexler
HDBuzz interviews Alice and Nancy Wexler, the sisters at the heart of the Hereditary Disease Foundation
-

Video: What’s new in Huntington's disease research 2012
Watch Ed Wild's address to the European Huntington's Association on how HD research works and the most promising poss
-

Shooting the messenger with single-stranded RNA gene silencing
New ‘single-stranded RNA’ gene silencing drugs could be safer & more effective to treat Huntington’s disease
-

EuroBuzz Video: Day 2
Watch the full video of EuroBuzz day 2 with Jeff Carroll and Ed Wild at the Euro-HD Network Meeting in Stockholm
-

EuroBuzz News: Day 2
EuroBuzz news: Day 2. Ed and Jeff reporting from the European Huntington’s Disease Network 2012 meeting in Stockholm
